25 XP   0   0   10

Suven Pharmaceuticals Limited
Buy, Hold or Sell?

Let's analyse Suven Pharmaceuticals Limited together

PenkeI guess you are interested in Suven Pharmaceuticals Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Suven Pharmaceuticals Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Suven Pharmaceuticals Limited

I send you an email if I find something interesting about Suven Pharmaceuticals Limited.

Quick analysis of Suven Pharmaceuticals Limited (30 sec.)










What can you expect buying and holding a share of Suven Pharmaceuticals Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.38
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR68.16
Expected worth in 1 year
INR100.85
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
INR64.68
Return On Investment
10.1%

For what price can you sell your share?

Current Price per Share
INR641.50
Expected price per share
INR599.05 - INR768.00
How sure are you?
50%

1. Valuation of Suven Pharmaceuticals Limited (5 min.)




Live pricePrice per Share (EOD)

INR641.50

Intrinsic Value Per Share

INR70.07 - INR81.39

Total Value Per Share

INR138.23 - INR149.55

2. Growth of Suven Pharmaceuticals Limited (5 min.)




Is Suven Pharmaceuticals Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$208.2m$183.2m$24.9m12.0%

How much money is Suven Pharmaceuticals Limited making?

Current yearPrevious yearGrowGrow %
Making money$49.3m$54.4m-$5.1m-10.3%
Net Profit Margin30.7%35.2%--

How much money comes from the company's main activities?

3. Financial Health of Suven Pharmaceuticals Limited (5 min.)




What can you expect buying and holding a share of Suven Pharmaceuticals Limited? (5 min.)

Welcome investor! Suven Pharmaceuticals Limited's management wants to use your money to grow the business. In return you get a share of Suven Pharmaceuticals Limited.

What can you expect buying and holding a share of Suven Pharmaceuticals Limited?

First you should know what it really means to hold a share of Suven Pharmaceuticals Limited. And how you can make/lose money.

Speculation

The Price per Share of Suven Pharmaceuticals Limited is INR641.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Suven Pharmaceuticals Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Suven Pharmaceuticals Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR68.16. Based on the TTM, the Book Value Change Per Share is INR8.17 per quarter. Based on the YOY, the Book Value Change Per Share is INR13.61 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR8.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Suven Pharmaceuticals Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.190.0%0.190.0%0.210.0%0.160.0%0.160.0%
Usd Book Value Change Per Share0.100.0%0.100.0%0.160.0%0.160.0%0.160.0%
Usd Dividend Per Share0.100.0%0.100.0%0.050.0%0.040.0%0.040.0%
Usd Total Gains Per Share0.190.0%0.190.0%0.210.0%0.200.0%0.200.0%
Usd Price Per Share5.67-5.67-7.42-4.05-4.05-
Price to Earnings Ratio29.24-29.24-34.69-23.00-23.00-
Price-to-Total Gains Ratio29.21-29.21-35.13-15.18-15.18-
Price to Book Ratio6.93-6.93-10.31-6.80-6.80-
Price-to-Total Gains Ratio29.21-29.21-35.13-15.18-15.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.698
Number of shares129
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.100.04
Usd Book Value Change Per Share0.100.16
Usd Total Gains Per Share0.190.20
Gains per Quarter (129 shares)25.0325.87
Gains per Year (129 shares)100.13103.50
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1505190198493
29910119038169196
314915229057253299
419820239076338402
524825349095422505
6297304590115506608
7347354690134591711
8396405790153675814
9446455890172760917
104955069901918441020

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%4.01.00.080.0%4.01.00.080.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%4.01.00.080.0%4.01.00.080.0%

Fundamentals of Suven Pharmaceuticals Limited

About Suven Pharmaceuticals Limited

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is headquartered in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited. As of September 29, 2023, Suven Pharmaceuticals Limited operates as a subsidiary of Berhyanda Limited.

Fundamental data was last updated by Penke on 2024-04-14 09:13:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Suven Pharmaceuticals Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Suven Pharmaceuticals Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Suven Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 30.7% means that ₹0.31 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Suven Pharmaceuticals Limited:

  • The MRQ is 30.7%. The company is making a huge profit. +2
  • The TTM is 30.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ30.7%TTM30.7%0.0%
TTM30.7%YOY35.2%-4.5%
TTM30.7%5Y34.4%-3.7%
5Y34.4%10Y34.4%0.0%
1.1.2. Return on Assets

Shows how efficient Suven Pharmaceuticals Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Suven Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 20.9% Return on Assets means that Suven Pharmaceuticals Limited generated ₹0.21 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Suven Pharmaceuticals Limited:

  • The MRQ is 20.9%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 20.9%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ20.9%TTM20.9%0.0%
TTM20.9%YOY24.8%-3.9%
TTM20.9%5Y22.3%-1.3%
5Y22.3%10Y22.3%0.0%
1.1.3. Return on Equity

Shows how efficient Suven Pharmaceuticals Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Suven Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 23.7% Return on Equity means Suven Pharmaceuticals Limited generated ₹0.24 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Suven Pharmaceuticals Limited:

  • The MRQ is 23.7%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 23.7%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ23.7%TTM23.7%0.0%
TTM23.7%YOY29.7%-6.0%
TTM23.7%5Y28.0%-4.3%
5Y28.0%10Y28.0%0.0%

1.2. Operating Efficiency of Suven Pharmaceuticals Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Suven Pharmaceuticals Limited is operating .

  • Measures how much profit Suven Pharmaceuticals Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Suven Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 42.3% means the company generated ₹0.42  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Suven Pharmaceuticals Limited:

  • The MRQ is 42.3%. The company is operating very efficient. +2
  • The TTM is 42.3%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ42.3%TTM42.3%0.0%
TTM42.3%YOY46.6%-4.3%
TTM42.3%5Y46.5%-4.2%
5Y46.5%10Y46.5%0.0%
1.2.2. Operating Ratio

Measures how efficient Suven Pharmaceuticals Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.61 means that the operating costs are ₹0.61 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Suven Pharmaceuticals Limited:

  • The MRQ is 0.613. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.613. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.613TTM0.6130.000
TTM0.613YOY0.579+0.034
TTM0.6135Y0.576+0.037
5Y0.57610Y0.5760.000

1.3. Liquidity of Suven Pharmaceuticals Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Suven Pharmaceuticals Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 6.37 means the company has ₹6.37 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Suven Pharmaceuticals Limited:

  • The MRQ is 6.368. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.368. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.368TTM6.3680.000
TTM6.368YOY5.364+1.005
TTM6.3685Y3.746+2.622
5Y3.74610Y3.7460.000
1.3.2. Quick Ratio

Measures if Suven Pharmaceuticals Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Suven Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 6.43 means the company can pay off ₹6.43 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Suven Pharmaceuticals Limited:

  • The MRQ is 6.430. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.430. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.430TTM6.4300.000
TTM6.430YOY6.297+0.132
TTM6.4305Y3.588+2.842
5Y3.58810Y3.5880.000

1.4. Solvency of Suven Pharmaceuticals Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Suven Pharmaceuticals Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Suven Pharmaceuticals Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.12 means that Suven Pharmaceuticals Limited assets are financed with 11.7% credit (debt) and the remaining percentage (100% - 11.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Suven Pharmaceuticals Limited:

  • The MRQ is 0.117. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.117. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.117TTM0.1170.000
TTM0.117YOY0.165-0.048
TTM0.1175Y0.202-0.084
5Y0.20210Y0.2020.000
1.4.2. Debt to Equity Ratio

Measures if Suven Pharmaceuticals Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Suven Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 13.3% means that company has ₹0.13 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Suven Pharmaceuticals Limited:

  • The MRQ is 0.133. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.133. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.133TTM0.1330.000
TTM0.133YOY0.198-0.065
TTM0.1335Y0.259-0.126
5Y0.25910Y0.2590.000

2. Market Valuation of Suven Pharmaceuticals Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Suven Pharmaceuticals Limited generates.

  • Above 15 is considered overpriced but always compare Suven Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 29.24 means the investor is paying ₹29.24 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Suven Pharmaceuticals Limited:

  • The EOD is 39.705. Based on the earnings, the company is overpriced. -1
  • The MRQ is 29.239. Based on the earnings, the company is overpriced. -1
  • The TTM is 29.239. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD39.705MRQ29.239+10.466
MRQ29.239TTM29.2390.000
TTM29.239YOY34.692-5.454
TTM29.2395Y22.996+6.243
5Y22.99610Y22.9960.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Suven Pharmaceuticals Limited:

  • The EOD is 98.887. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 72.821. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 72.821. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD98.887MRQ72.821+26.067
MRQ72.821TTM72.8210.000
TTM72.821YOY61.785+11.036
TTM72.8215Y39.434+33.387
5Y39.43410Y39.4340.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Suven Pharmaceuticals Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 6.93 means the investor is paying ₹6.93 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Suven Pharmaceuticals Limited:

  • The EOD is 9.411. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.930. Based on the equity, the company is overpriced. -1
  • The TTM is 6.930. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD9.411MRQ6.930+2.481
MRQ6.930TTM6.9300.000
TTM6.930YOY10.309-3.378
TTM6.9305Y6.802+0.129
5Y6.80210Y6.8020.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Suven Pharmaceuticals Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--8.1718.1710%13.606-40%13.633-40%13.633-40%
Book Value Per Share--68.16368.1630%59.992+14%42.864+59%42.864+59%
Current Ratio--6.3686.3680%5.364+19%3.746+70%3.746+70%
Debt To Asset Ratio--0.1170.1170%0.165-29%0.202-42%0.202-42%
Debt To Equity Ratio--0.1330.1330%0.198-33%0.259-49%0.259-49%
Dividend Per Share--8.0008.0000%4.000+100%3.082+160%3.082+160%
Eps--16.15716.1570%17.827-9%12.949+25%12.949+25%
Free Cash Flow Per Share--6.4876.4870%10.010-35%6.634-2%6.634-2%
Free Cash Flow To Equity Per Share---2.777-2.7770%3.865-172%3.180-187%3.180-187%
Gross Profit Margin--0.9570.9570%0.956+0%0.957+0%0.957+0%
Intrinsic Value_10Y_max--81.390--------
Intrinsic Value_10Y_min--70.070--------
Intrinsic Value_1Y_max--8.892--------
Intrinsic Value_1Y_min--8.640--------
Intrinsic Value_3Y_max--26.155--------
Intrinsic Value_3Y_min--24.712--------
Intrinsic Value_5Y_max--42.743--------
Intrinsic Value_5Y_min--39.292--------
Market Cap163303442368.000+26%120256506000.000120256506000.0000%157435719302.400-24%91068591240.480+32%91068591240.480+32%
Net Profit Margin--0.3070.3070%0.352-13%0.344-11%0.344-11%
Operating Margin--0.4230.4230%0.466-9%0.465-9%0.465-9%
Operating Ratio--0.6130.6130%0.579+6%0.576+6%0.576+6%
Pb Ratio9.411+26%6.9306.9300%10.309-33%6.802+2%6.802+2%
Pe Ratio39.705+26%29.23929.2390%34.692-16%22.996+27%22.996+27%
Price Per Share641.500+26%472.400472.4000%618.450-24%337.636+40%337.636+40%
Price To Free Cash Flow Ratio98.887+26%72.82172.8210%61.785+18%39.434+85%39.434+85%
Price To Total Gains Ratio39.670+26%29.21329.2130%35.126-17%15.180+92%15.180+92%
Quick Ratio--6.4306.4300%6.297+2%3.588+79%3.588+79%
Return On Assets--0.2090.2090%0.248-16%0.223-6%0.223-6%
Return On Equity--0.2370.2370%0.297-20%0.280-15%0.280-15%
Total Gains Per Share--16.17116.1710%17.606-8%16.715-3%16.715-3%
Usd Book Value--208222116.000208222116.0000%183261648.000+14%141077431.200+48%141077431.200+48%
Usd Book Value Change Per Share--0.0980.0980%0.163-40%0.164-40%0.164-40%
Usd Book Value Per Share--0.8180.8180%0.720+14%0.514+59%0.514+59%
Usd Dividend Per Share--0.0960.0960%0.048+100%0.037+160%0.037+160%
Usd Eps--0.1940.1940%0.214-9%0.155+25%0.155+25%
Usd Free Cash Flow--19816908.00019816908.0000%30577620.000-35%24064809.600-18%24064809.600-18%
Usd Free Cash Flow Per Share--0.0780.0780%0.120-35%0.080-2%0.080-2%
Usd Free Cash Flow To Equity Per Share---0.033-0.0330%0.046-172%0.038-187%0.038-187%
Usd Market Cap1959641308.416+26%1443078072.0001443078072.0000%1889228631.629-24%1092823094.886+32%1092823094.886+32%
Usd Price Per Share7.698+26%5.6695.6690%7.421-24%4.052+40%4.052+40%
Usd Profit--49354836.00049354836.0000%54456588.000-9%39689112.000+24%39689112.000+24%
Usd Revenue--160839456.000160839456.0000%154776456.000+4%114798391.200+40%114798391.200+40%
Usd Total Gains Per Share--0.1940.1940%0.211-8%0.201-3%0.201-3%
 EOD+4 -4MRQTTM+0 -0YOY+14 -225Y+18 -1810Y+18 -18

3.2. Fundamental Score

Let's check the fundamental score of Suven Pharmaceuticals Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1539.705
Price to Book Ratio (EOD)Between0-19.411
Net Profit Margin (MRQ)Greater than00.307
Operating Margin (MRQ)Greater than00.423
Quick Ratio (MRQ)Greater than16.430
Current Ratio (MRQ)Greater than16.368
Debt to Asset Ratio (MRQ)Less than10.117
Debt to Equity Ratio (MRQ)Less than10.133
Return on Equity (MRQ)Greater than0.150.237
Return on Assets (MRQ)Greater than0.050.209
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Suven Pharmaceuticals Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.430
Ma 20Greater thanMa 50643.863
Ma 50Greater thanMa 100648.180
Ma 100Greater thanMa 200669.092
OpenGreater thanClose645.450
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets19,657,438
Total Liabilities2,305,595
Total Stockholder Equity17,351,843
 As reported
Total Liabilities 2,305,595
Total Stockholder Equity+ 17,351,843
Total Assets = 19,657,438

Assets

Total Assets19,657,438
Total Current Assets10,110,458
Long-term Assets9,546,980
Total Current Assets
Cash And Cash Equivalents 648,028
Short-term Investments 4,224,279
Net Receivables 1,111,322
Inventory 3,128,105
Other Current Assets 998,724
Total Current Assets  (as reported)10,110,458
Total Current Assets  (calculated)10,110,458
+/-0
Long-term Assets
Property Plant Equipment 7,662,249
Intangible Assets 621,902
Long-term Assets Other 32,519
Long-term Assets  (as reported)9,546,980
Long-term Assets  (calculated)8,316,670
+/- 1,230,310

Liabilities & Shareholders' Equity

Total Current Liabilities1,587,658
Long-term Liabilities717,937
Total Stockholder Equity17,351,843
Total Current Liabilities
Short-term Debt 650,768
Short Long Term Debt 645,978
Accounts payable 651,643
Other Current Liabilities 29,527
Total Current Liabilities  (as reported)1,587,658
Total Current Liabilities  (calculated)1,977,916
+/- 390,258
Long-term Liabilities
Long term Debt 45,642
Capital Lease Obligations 11,788
Long-term Liabilities  (as reported)717,937
Long-term Liabilities  (calculated)57,430
+/- 660,507
Total Stockholder Equity
Common Stock254,565
Retained Earnings 14,651,606
Accumulated Other Comprehensive Income 1,349,934
Other Stockholders Equity 1,095,738
Total Stockholder Equity (as reported)17,351,843
Total Stockholder Equity (calculated)17,351,843
+/-0
Other
Capital Stock254,565
Cash and Short Term Investments 4,872,307
Common Stock Shares Outstanding 254,565
Current Deferred Revenue255,720
Liabilities and Stockholders Equity 19,657,438
Net Debt 55,380
Net Invested Capital 18,043,463
Net Working Capital 8,522,800
Property Plant and Equipment Gross 7,662,249
Short Long Term Debt Total 703,408



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-31
> Total Assets 
7,830,163
11,728,105
14,744,651
18,295,873
19,657,438
19,657,43818,295,87314,744,65111,728,1057,830,163
   > Total Current Assets 
3,897,342
3,916,467
5,647,852
11,279,320
10,110,458
10,110,45811,279,3205,647,8523,916,4673,897,342
       Cash And Cash Equivalents 
109,030
116,953
71,822
445,638
648,028
648,028445,63871,822116,953109,030
       Short-term Investments 
70,638
306,761
1,805,938
4,812,224
4,224,279
4,224,2794,812,2241,805,938306,76170,638
       Net Receivables 
2,112,253
1,744,032
1,759,135
3,172,722
1,111,322
1,111,3223,172,7221,759,1351,744,0322,112,253
       Inventory 
1,570,982
1,748,723
2,010,804
2,834,173
3,128,105
3,128,1052,834,1732,010,8041,748,7231,570,982
       Other Current Assets 
34,439
-2
153
14,563
998,724
998,72414,563153-234,439
   > Long-term Assets 
3,932,821
7,811,638
9,096,799
7,016,553
9,546,980
9,546,9807,016,5539,096,7997,811,6383,932,821
       Property Plant Equipment 
3,792,808
4,556,530
5,348,896
5,619,513
7,662,249
7,662,2495,619,5135,348,8964,556,5303,792,808
       Intangible Assets 
26,851
27,960
25,904
22,364
621,902
621,90222,36425,90427,96026,851
       Other Assets 
112,457
152,593
110,159
203,710
0
0203,710110,159152,593112,457
> Total Liabilities 
1,927,257
3,280,478
2,936,568
3,024,069
2,305,595
2,305,5953,024,0692,936,5683,280,4781,927,257
   > Total Current Liabilities 
1,576,087
2,003,715
2,197,480
2,102,940
1,587,658
1,587,6582,102,9402,197,4802,003,7151,576,087
       Short-term Debt 
827,936
944,421
1,067,058
682,239
650,768
650,768682,2391,067,058944,421827,936
       Short Long Term Debt 
827,936
940,380
1,056,376
671,331
645,978
645,978671,3311,056,376940,380827,936
       Accounts payable 
535,749
710,557
829,313
1,059,007
651,643
651,6431,059,007829,313710,557535,749
       Other Current Liabilities 
211,306
39,084
22,564
20,990
29,527
29,52720,99022,56439,084211,306
   > Long-term Liabilities 
351,170
1,276,763
739,088
921,129
717,937
717,937921,129739,0881,276,763351,170
       Other Liabilities 
351,170
359,118
375,889
632,096
0
0632,096375,889359,118351,170
> Total Stockholder Equity
5,902,905
8,447,627
11,808,083
15,271,803
17,351,843
17,351,84315,271,80311,808,0838,447,6275,902,905
   Common Stock
127,282
127,282
254,565
254,565
254,565
254,565254,565254,565127,282127,282
   Retained Earnings 
3,909,835
6,154,443
9,364,926
12,727,086
14,651,606
14,651,60612,727,0869,364,9266,154,4433,909,835
   Capital Surplus 00000
   Treasury Stock00000
   Other Stockholders Equity 
1,865,788
1,223,022
1,095,738
1,095,738
1,095,738
1,095,7381,095,7381,095,7381,223,0221,865,788



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue13,403,288
Cost of Revenue-5,854,225
Gross Profit7,549,0637,549,063
 
Operating Income (+$)
Gross Profit7,549,063
Operating Expense-2,361,040
Operating Income5,188,0235,188,023
 
Operating Expense (+$)
Research Development85,857
Selling General Administrative188,974
Selling And Marketing Expenses176,359
Operating Expense2,361,040451,190
 
Net Interest Income (+$)
Interest Income58,316
Interest Expense-54,363
Other Finance Cost-58,316
Net Interest Income-54,363
 
Pretax Income (+$)
Operating Income5,188,023
Net Interest Income-54,363
Other Non-Operating Income Expenses0
Income Before Tax (EBT)5,597,2984,778,748
EBIT - interestExpense = 5,610,023
5,597,298
4,167,266
Interest Expense54,363
Earnings Before Interest and Taxes (EBIT)5,664,3865,651,661
Earnings Before Interest and Taxes (EBITDA)6,128,985
 
After tax Income (+$)
Income Before Tax5,597,298
Tax Provision-1,484,395
Net Income From Continuing Ops4,112,9034,112,903
Net Income4,112,903
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses8,215,265
Total Other Income/Expenses Net409,27554,363
 

Technical Analysis of Suven Pharmaceuticals Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Suven Pharmaceuticals Limited. The general trend of Suven Pharmaceuticals Limited is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Suven Pharmaceuticals Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Suven Pharmaceuticals Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 693.95 < 730.00 < 768.00.

The bearish price targets are: 605.35 > 600.00 > 599.05.

Tweet this
Suven Pharmaceuticals Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Suven Pharmaceuticals Limited. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Suven Pharmaceuticals Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Suven Pharmaceuticals Limited. The current macd is -2.51936387.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Suven Pharmaceuticals Limited price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Suven Pharmaceuticals Limited. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Suven Pharmaceuticals Limited price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Suven Pharmaceuticals Limited Daily Moving Average Convergence/Divergence (MACD) ChartSuven Pharmaceuticals Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Suven Pharmaceuticals Limited. The current adx is 9.76587337.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Suven Pharmaceuticals Limited shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Suven Pharmaceuticals Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Suven Pharmaceuticals Limited. The current sar is 673.38.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Suven Pharmaceuticals Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Suven Pharmaceuticals Limited. The current rsi is 49.43. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Suven Pharmaceuticals Limited Daily Relative Strength Index (RSI) ChartSuven Pharmaceuticals Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Suven Pharmaceuticals Limited. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Suven Pharmaceuticals Limited price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Suven Pharmaceuticals Limited Daily Stochastic Oscillator ChartSuven Pharmaceuticals Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Suven Pharmaceuticals Limited. The current cci is -7.74401667.

Suven Pharmaceuticals Limited Daily Commodity Channel Index (CCI) ChartSuven Pharmaceuticals Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Suven Pharmaceuticals Limited. The current cmo is 1.00673153.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Suven Pharmaceuticals Limited Daily Chande Momentum Oscillator (CMO) ChartSuven Pharmaceuticals Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Suven Pharmaceuticals Limited. The current willr is -45.35147392.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Suven Pharmaceuticals Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Suven Pharmaceuticals Limited Daily Williams %R ChartSuven Pharmaceuticals Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Suven Pharmaceuticals Limited.

Suven Pharmaceuticals Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Suven Pharmaceuticals Limited. The current atr is 23.06.

Suven Pharmaceuticals Limited Daily Average True Range (ATR) ChartSuven Pharmaceuticals Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Suven Pharmaceuticals Limited. The current obv is 45,125,980.

Suven Pharmaceuticals Limited Daily On-Balance Volume (OBV) ChartSuven Pharmaceuticals Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Suven Pharmaceuticals Limited. The current mfi is 50.19.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Suven Pharmaceuticals Limited Daily Money Flow Index (MFI) ChartSuven Pharmaceuticals Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Suven Pharmaceuticals Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Suven Pharmaceuticals Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Suven Pharmaceuticals Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.430
Ma 20Greater thanMa 50643.863
Ma 50Greater thanMa 100648.180
Ma 100Greater thanMa 200669.092
OpenGreater thanClose645.450
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Suven Pharmaceuticals Limited with someone you think should read this too:
  • Are you bullish or bearish on Suven Pharmaceuticals Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Suven Pharmaceuticals Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Suven Pharmaceuticals Limited

I send you an email if I find something interesting about Suven Pharmaceuticals Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Suven Pharmaceuticals Limited.

Receive notifications about Suven Pharmaceuticals Limited in your mailbox!